PMID: 9546672Apr 18, 1998Paper

Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation

European Journal of Biochemistry
Q Zheng-FischhöferE M Mandelkow

Abstract

AT100 is a monoclonal antibody highly specific for phosphorylated Tau in Alzheimer paired helical filaments. Here we show that the epitope is generated by a complex sequence of sequential phosphorylation, first of Ser199, Ser202 and Thr205 (around the epitope of antibody AT8), next of Thr212 by glycogen synthase kinase (GSK)-3beta (a proline-directed kinase), then of Ser214 by protein kinase A (PKA). Conversely, if Ser214 is phosphorylated first it protects Thr212 and the Ser-Pro motifs around the AT8 site against phosphorylation, and the AT100 epitope is not formed. The generation of the AT100 epitope requires a conformation of tau induced by polyanions such as heparin, RNA or poly(Glu), conditions which also favor the formation of paired helical filaments. The Alzheimer-like phosphorylation can be induced by brain extracts. In the extract, the kinases responsible for generating the AT100 epitope are GSK-3beta and PKA, which can be inhibited by their specific inhibitors LiCl and RII, respectively. A cellular model displaying the reaction with AT100 is presented by Sf9 insect cells transfected with Tau. Knowledge of the events and kinases generating the AT100 epitope in cells might allow us to study the degeneration of the cyto...Continue Reading

Citations

Nov 1, 2000·Cell Motility and the Cytoskeleton·H Ksiezak-RedingD W Dickson
Oct 17, 2001·Annals of Neurology·M NeumannH A Kretzschmar
Jan 13, 2005·Acta Neuropathologica·Khalid Iqbal, Inge Grundke-Iqbal
Oct 12, 2013·Acta Neuropathologica·Rachel M BaileyJada Lewis
Feb 3, 2009·Journal of Neural Transmission·Jens Thorsten StielerThomas Arendt
Nov 28, 2009·Cellular and Molecular Neurobiology·Carmen ValeLuis M Botana
Jun 18, 2011·Molecular Neurobiology·Katerina Papanikolopoulou, Efthimios M C Skoulakis
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Anja Schneider, Eckhard Mandelkow
Sep 1, 2000·Brain Research. Brain Research Reviews·G V De Ferrari, N C Inestrosa
Jun 26, 2001·Brain Research. Brain Research Reviews·J Götz
Aug 21, 2003·Neurobiology of Aging·Jane LaucknerChangiz Geula
Nov 9, 2002·Journal of Neurochemistry·Patrice DelobelLuc Buée
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro OhmiElizabeth F Neufeld
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·A Shanavas, S C Papasozomenos
Nov 14, 2002·Molecular Biology of the Cell·Jacek BiernatEva-Maria Mandelkow
Oct 12, 2007·Molecular Biology of the Cell·Michelle L SteinhilbMel B Feany
Oct 22, 2008·Human Molecular Genetics·Shreyasi ChatterjeeGeorge R Jackson
Oct 12, 1999·Brain Pathology·S H YenP Nacharaju
Jul 20, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bing ZhuTroy Stevens
Jan 8, 2011·Neuro-degenerative Diseases·Arianna BellucciMaria Grazia Spillantini
Jan 25, 2013·Journal of Cell Science·Matthew E SewardGeorge S Bloom
Jun 30, 2000·Biochemical and Biophysical Research Communications·T IsagawaY Ono
Jun 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·A AlonsoK Iqbal
Oct 17, 2013·Journal of Neuropathology and Experimental Neurology·Robert SimanYina Dong
May 12, 2011·International Journal of Alzheimer's Disease·Ann De VosErwin Swinnen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.